Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: Impact of hyperglycemia

Thrombosis and Haemostasis

Volumn 98, Issue 5, 2007, Pages 1007-1013

  Gentile, Nina T ^a   Vaidyula, Vijender R ^a   Kanamalla, Uday ^a   DeAngelis, Michael ^a   Gaughan, John ^a   Rao, A Koneti ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Hyperglycemia; Procoagulant state; Stroke; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FACTOR VIIA; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOPHILIA; THROMBOPLASTIN;

EID: 36048935090     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-12-0719     Document Type: Article

References (43)

1. Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59: 67-71.
2. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 10; 59: 669-674.
3. Gentile NT, Seftchick M, Chen T, et al. Decreased mortality with normalizing blood glucose after acute ischemic stroke. Acad Emer Med 2006; 13: 174-180.
4. Ceriello A. Coagulation activation in diabetes mellitus: The role of hyperglycaemia and therapeutic prospects. Diabetologia 1993; 36: 1119-1125.
5. Dunn EJ, Grant PJ. Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med 2005; 5: 323-332.
6. Leurs PB, Stolk RP, Hamulyak K, et al. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care 2002; 25: 1340-1345.
7. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10: 139-143.
8. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vase Biol 2004; 24: 1015-1022.
9. Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
10. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315.
11. Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91: 4216-4223.
12. Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190-3197.
13. Abdel-Hafiz E, Vaidyula VR, Bagga S, et al. Elevated whole blood tissue factor procoagulant activity in diabetes mellitus: vitamin E inhibits glucose induced tissue factor activity in vitro. Blood 2002; 100: 496a.
14. Sambola A, Osende J, Hathcock J, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003; 107: 973-977.
15. Tutar E, Ozcan M, Kilickap M, et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 2003; 108: 1581-1584.
16. Rao AK, Vaidyula VR, Bagga S, et al. Effect of anti-platelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease. Thromb Haemost 2006; 96: 738-743.
17. Asakura H, Kamikubo Y, Goto A, et al. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80: 217-224.
18. Vaidyula VR, Rao AK, Mozzoli M, et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006; 55: 202-208.
19. Smith, FB. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-3325.
20. Takano, K. Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res 1990; 58: 481-491.
21. He M, Wen Z, He X, et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute celebrocardiac thrombotic diseases. Thromb Res 2002; 107: 223-228.
22. Berge E, Friis P, Sandset PM. Hemostatic activation in acute ischemic stroke. Thromb Res 2001; 101: 13-21.
23. Soncini K Gasparini P, Lorena M, et al. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke. Minerva Cardioangiol 2000; 48: 349-356.
24. Cote R, Wolfson C, Solymoss S, et al. Hemostatic markers in patients at risk of cerebral ischemia. Stroke 2000; 8: 1856-1862.
25. American Stroke Association. Available at http://asa.trainingcampus.net/.
26. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametnc statistics. Am Statistician 1981; 35: 124-129.
27. Moreno PR, Foster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004; 44: 2293-2300.
28. Martin A, Rojas S, Chamorro A, et al. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Stroke 2006; 37: 1288-1295.
29. Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. J Am Med Assoc 2000; 283: 221-228.
30. Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Quart J Med 1994; 87: 403-436.
31. Morel O, Hugel B, Jesel L, et. al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004; 91: 345-353.
32. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost. 2006; 32: 32-38.
33. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
34. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 98: 1082-1088.
35. Van den Berghe G, Wilmer A, Herman H, et al. Intensive Insulin Therapy in the Medical ICU. N Engl J Med 2006; 354: 449-461.
36. DeSantis AJ, Schmidt K, O'Shea-Mahler E, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract 2006; 12: 491-505.
37. Malmberg K. Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Endocr Pract 2004; 10 (Suppl 2): 13-16.
38. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: A randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29: 765-770.
39. Berger L, Hakim AM. The association of hyperglycemia with cerebral edema in stroke. Stroke 1986; 17: 865-871.
40. Mohanty P, Hamouda W, Garg R, et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. 2000;85:2970-73.
41. Tripathy D, Mohanty P, Dhindsa S, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003; 52: 2882-2887.
42. Dhindsa S, Tripathy D, Mohanty P et al. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism 2004; 53: 330-334.
43. Aljada A, Ghanim H, Mohanty P, et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 2002; 97: 1419-1422.